Pre-Conference Workshop Day

Tuesday January 26, 2020
10am - 5pm EST | 7am - 2pm PST

Please note that all agenda timings are Eastern time.
For PDT time, please download the program here.

Workshop A
10:00 - 13:00 | 07:00 - 10:00

Integration of Machine Learning Across the Value Chain

Machine learning has many faces and applications - there is real potential to transform the pharma value chain. But changing established processes in a traditional industry can be an uphill struggle. This workshop will provide the blueprint for successful translation of technologies from early stage R&D to later stage commercial - as well as guidelines to pick the right tech for your specific problems.

Topics of discussion include:

• Marry specific problems with a solution instead of a type of technology
• How to select which platform is right for each department
• Translate successful applications to work in later stage clinical trials

Ronald Dorenbos

Your Workshop Leader:

Ronald Dorenbos
Former Associate Director, Materials & Innovation
Takeda

Workshop B
14:00 - 17:00 | 11:00 - 14:00

Artificial Intelligence, Drug Repurposing & Covid-19

From the onset of Covid-19, organizations from many different backgrounds have been quick to transition resources and apply their artificial intelligence expertise across the full spectrum of drug discovery and development. It is clear artificial intelligence and machine learning can play a large role in overcoming the crisis by enabling the medical community, policy makers and general public with the right tools to manage every stage of the crisis; from detection, prevention and response, to recovery and accelerating research and treatment efforts.
This workshop details drug repositioning efforts in finding candidates with the optimal profile for clinical success.

Topics of discussion include:

• Discussing ML and its use to identify biological targets for therapeutic intervention in heterogeneous disease and find suitable drug candidates that bind those targets
• Machine learning models for estimating small molecule activity from molecular structure, for a range of SARS-CoV-2 related assays
• Highlighting the need for new tools to complement existing peer-review mechanisms for ensuring the veracity and robustness of the biomedical information published to guide clinical practice and shape public health policy

TudorOprea

Your Workshop Leader:

Tudor Oprea
Professor - Medicine & Chief of Translational Informatics Division & Internal Medicine
University of New Mexico